Integra Lifesciences Holdings Corp (NASDAQ:IART)
| 41.27 Delayed Data As of Dec 08 |  -0.04 / -0.10%Today’s Change | 33.44 Today|||52-Week Range 60.69 | -26.40% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Assets | Cash | 206.0M | 138.8M | 157.0M | 176.1M | |
| Short Term Investment Cash | 22.2M | -67.2M | 18.2M | 19.1M | ||
| Cash & Short Term Investments | 206.0M | 138.8M | 157.0M | 176.1M | ||
| Receivables | Receivables | 248.7M | 269.9M | 279.1M | 296.5M | |
| Inventories | Inventories | 290.8M | 280.3M | 287.0M | 296.5M | |
| Current Assets | Other Current Assets | 82.4M | 86.0M | 99.6M | 99.6M | |
| Current Assets | 828.0M | 775.1M | 822.7M | 868.7M | ||
| Total Assets | Property, Plant and Equipment - Gross | -- | 555.3M | -- | -- | |
| Depreciation | -- | -255.2M | -- | -- | ||
| Intangible Assets | 2.0B | 2.0B | 2.0B | 2.0B | ||
| Other Assets | 2.0B | 2.0B | 2.0B | 2.0B | ||
| Total Assets | 3.2B | 3.1B | 3.2B | 3.3B | ||
| Liabilities | Accounts Payable | 86.4M | 76.1M | 100.6M | 107.2M | |
| Short Term Debt | 11.3M | 22.5M | 33.8M | 58.4M | ||
| Accrued Expenses | 84.3M | 80.7M | 76.0M | 78.7M | ||
| Other Current Liabilities | 89.3M | 88.3M | 96.2M | 85.2M | ||
| Other Liabilities | 258.3M | 262.6M | 288.1M | 315.1M | ||
| Total Liabilities | Long Term Debt | 1.4B | 1.3B | 1.4B | 1.4B | |
| Deferred Taxes | -65.8M | -51.0M | -41.3M | -30.6M | ||
| Other Liabilities | 61.2M | 49.5M | 61.6M | 93.0M | ||
| Total Liabilities | 1.8B | 1.7B | 1.8B | 1.9B | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 1.4B | 1.4B | 1.4B | 1.4B | ||
| Total Shareholder Equity | 1.4B | 1.4B | 1.4B | 1.4B | ||
| Share Information | Common Shares Outstanding | 85.1M | 85.2M | 85.4M | 85.5M | |
| Addtl. Info. | No data currently available for this section. | |||||
